» Articles » PMID: 35261902

A Narrative Review for the Hippo-YAP Pathway in Cancer Survival and Immunity: the Yin-Yang Dynamics

Overview
Specialty Oncology
Date 2022 Mar 9
PMID 35261902
Authors
Affiliations
Soon will be listed here.
Abstract

The Hippo-YAP pathway is fast becoming a key instrument in regulating cancers. Binary oppositions, also known as the Yin-Yang dynamics in Chinese, have emerged in its effects. Some oppositions are attributable to and experimental conditions, some are due to differences between cancers or species, some are derived from its inherent duality endowed by upstream and downstream signaling, and some are yet unresolved mysteries. However, as bewildering they are, few have been noticed and defined so far. In this review, we first look back on the Hippo pathway which was initially identified more than a decade ago. We then focus on tumor biology, especially some latest popular mechanisms that regulate tumor cell survival, such as ferroptosis, autophagy, and apoptosis. The third chapter is concerned with the findings of the relationship between the Hippo pathway and tumor immunity on the microenvironment in which tumor cells progress. In each of these main sections the contradictory points of the Hippo pathway are elucidated and thoroughly examined. On one hand, the Yin-Yang dynamics of the Hippo pathway brings about considerable challenges for current research; on the other hand, this work will generate fresh insight into it and offer opportunities for subsequent drug development for cancer and regenerative medicine.

Citing Articles

Broadening horizons: the multifaceted role of ferroptosis in breast cancer.

Ge A, Xiang W, Li Y, Zhao D, Chen J, Daga P Front Immunol. 2024; 15:1455741.

PMID: 39664391 PMC: 11631881. DOI: 10.3389/fimmu.2024.1455741.


HIF‑1α inhibits ferroptosis and promotes malignant progression in non‑small cell lung cancer by activating the Hippo‑YAP signalling pathway.

Zheng S, Mo J, Zhang J, Chen Y Oncol Lett. 2023; 25(3):90.

PMID: 36817050 PMC: 9932041. DOI: 10.3892/ol.2023.13676.


Expression of the Hippo Pathway Core Components in Endometrial Cancer and Its Association with Clinicopathologic Features.

Yang J, Song D, Kim C, Kim M, Jo H, Kim H Diagnostics (Basel). 2022; 12(12).

PMID: 36552980 PMC: 9776728. DOI: 10.3390/diagnostics12122973.


Molecular Mechanism of Curcumin Derivative on YAP Pathway against Ovarian Cancer.

Zheng N, Liu S, Zeng H, Zhao H, Jin L J Clin Med. 2022; 11(23).

PMID: 36498794 PMC: 9740724. DOI: 10.3390/jcm11237220.


Smoke-induced SAV1 Gene Promoter Hypermethylation Disrupts YAP Negative Feedback and Promotes Malignant Progression of Non-small Cell Lung Cancer.

Liu T, Guo W, Luo K, Li L, Dong J, Liu M Int J Biol Sci. 2022; 18(11):4497-4512.

PMID: 35864957 PMC: 9295071. DOI: 10.7150/ijbs.73428.

References
1.
Hong A, Meng Z, Plouffe S, Lin Z, Zhang M, Guan K . Critical roles of phosphoinositides and NF2 in Hippo pathway regulation. Genes Dev. 2020; 34(7-8):511-525. PMC: 7111263. DOI: 10.1101/gad.333435.119. View

2.
Yuan Z, Shioya H, Ishiko T, Sun X, Gu J, Huang Y . p73 is regulated by tyrosine kinase c-Abl in the apoptotic response to DNA damage. Nature. 1999; 399(6738):814-7. DOI: 10.1038/21704. View

3.
Lee Y, Noon L, Akat K, Ybanez M, Lee T, Berres M . Autophagy is a gatekeeper of hepatic differentiation and carcinogenesis by controlling the degradation of Yap. Nat Commun. 2018; 9(1):4962. PMC: 6251897. DOI: 10.1038/s41467-018-07338-z. View

4.
Fu V, Plouffe S, Guan K . The Hippo pathway in organ development, homeostasis, and regeneration. Curr Opin Cell Biol. 2018; 49:99-107. PMC: 6348871. DOI: 10.1016/j.ceb.2017.12.012. View

5.
Saladi S, Ross K, Karaayvaz M, Tata P, Mou H, Rajagopal J . ACTL6A Is Co-Amplified with p63 in Squamous Cell Carcinoma to Drive YAP Activation, Regenerative Proliferation, and Poor Prognosis. Cancer Cell. 2017; 31(1):35-49. PMC: 5225026. DOI: 10.1016/j.ccell.2016.12.001. View